Kuvatris Therapeutics, Inc.

CIK 1811623 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Kuvatris Therapeutics, Inc..

Recent SEC filings

FiledFormAccession number
Jan 14, 202610-Q0001493152-26-002270
Aug 8, 202525-NSE0001354457-25-000791
Jun 13, 202515-12G0001641172-25-015071
Jun 13, 20258-K0001641172-25-015067
Apr 4, 20258-K0001641172-25-002752
Mar 7, 20258-K0001493152-25-009548
Feb 14, 2025SCHEDULE 13G/A0000929638-25-000806
Feb 6, 20258-K0001493152-25-005181
Nov 14, 2024NT 10-Q0001493152-24-045812
Nov 14, 2024SC 13G/A0000929638-24-003925
Oct 15, 2024EFFECT9999999995-24-003189
Oct 3, 2024S-10001493152-24-039370
Sep 20, 202410-Q0001558370-24-012929
Sep 6, 20248-K0001493152-24-035317
Aug 14, 2024NT 10-Q0001493152-24-032259
Jul 19, 20248-K0001493152-24-028508
Jun 14, 20248-K0001104659-24-071809
May 28, 20248-K0001104659-24-065618
May 15, 20248-K0001104659-24-061642
May 13, 202410-Q0001558370-24-007980
May 1, 20248-K0001104659-24-055841
Apr 23, 20248-K0001104659-24-050379
Apr 16, 20248-K0001104659-24-047818
Apr 15, 2024DEF 14A0001558370-24-005122
Apr 15, 2024ARS0001558370-24-005125